MIRM - NASDAQ

Mirum Pharmaceuticals, Inc.

MIRM·NASDAQ

$91.83

+1.5%

HealthcareBiotechnology

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$4.61B

EPS-0.4700

P/E Ratio-169.72

Earnings Date07/30/2026

mirm

Intangible Assets

Last Annual Value

260.92M

3-Year CAGR

64%

5-Year CAGR

10-Year CAGR

Adjust for Inflation

Mirum Pharmaceuticals, Inc. Competitors Analysis of Intangible Assets

MIRM · NASDAQ

Company	Intangible Assets	CAGR 3Y	CAGR 5Y	CAGR 10Y
Mirum Pharmaceuticals, Inc. NASDAQ:MIRM	260.92M	1.0%	69.3%	N/A
Dyne Therapeutics, Inc. NASDAQ:DYN	0.00	N/A	N/A	N/A
Praxis Precision Medicines, Inc. NASDAQ:PRAX	0.00	N/A	N/A	N/A
Ultragenyx Pharmaceutical Inc. NASDAQ:RARE	176.00M	1.9%	6.1%	N/A
Soleno Therapeutics, Inc. NASDAQ:SLNO	4.86M	-17.8%	-17.4%	19.5%
ADMA Biologics, Inc. NASDAQ:ADMA	632.00K	8.2%	-18.2%	N/A
ACADIA Pharmaceuticals Inc. NASDAQ:ACAD	108.89M	18.5%	N/A	31.6%
Travere Therapeutics, Inc. NASDAQ:TVTX	113.87M	3.2%	-5.0%	-4.6%
Belite Bio, Inc NASDAQ:BLTE	4.92M	15.0%	N/A	N/A
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	422.31M	12.1%	1.8%	32.2%

Mirum Pharmaceuticals, Inc. Fair Value Envelope

MIRM · NASDAQ

Our analysis suggests that MIRM has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $91.835, this represents a potential HIDDEN relative to our calculated worth for Mirum Pharmaceuticals, Inc..

HIDDEN

Intrinsic Value

Current Price: $91.835

Related Guides

Blog Categories

Continue your MIRM research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.